메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류
인문학
인문학 일반 역사학 철학 종교학 어문학 기타 인문학
사회과학
사회과학 일반 경영학 관광학 교육학 군사학 문헌정보학 법학 사회학 신문방송학 심리과학 정치외교학 지리학 행정학 경제학 무역학 인류학 기타 사회과학
자연과학
자연과학 일반 물리학 생물학 생활과학 수학·통계학 천문학 지구과학 화학 기타 자연과학
공학
공학 일반 건축공학 기계공학 산업공학 재료·에너지공학 전기전자공학 조선해양공학 화학공학 컴퓨터학 기타공학
의약학
의학 일반 간호학 수의학 약학 한의학 기초의학 임상의학 기타 의약학
농수해양학
농수해양학 일반 농학 수산학 식품과학 임학 축산학 해상운송학 기타 농수해양학
예술체육학
예술 일반 디자인 미술 미용 사진 음악학 의상 체육 공연매체예술 기타 예술체육학
복합학
학제간연구 과학기술학 뇌인지과학 기술정책 기타 복합학

ENG

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국병원약사회 병원약사회지 병원약사회지 제36권 제1호
발행연도
2019.1
수록면
78 - 87 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Apixaban is non-inferior to warfarin in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. The clinical use of apixaban in older patients is carefully regulated by the Health Insurance Review and Assessment Service in South Korea, due to a high bleeding risk. This study aimed to evaluate the patterns of apixaban use and medication adherence. A retrospective study was conducted using the electronic medical record (EMR). The study included patients who were 65 years and older with non-valvular atrial fibrillation who were prescribed apixaban from July 1, 2016, to June 30, 2017, in an ambulatory care setting in the Seoul National University Bundang Hospital. We assessed apixaban usage, concomitant medications, and adverse events based on information from the Ministry of Food and Drug Safety. The medication adherence was calculated by cumulative medication adherence (CMA), with appropriate medication adherence defined as a CMA equal to or higher than 80 percent. Among the 553 eligible patients, 243 patients were excluded because they were prescribed apixaban during hospitalization, baseline data were unavailable, or they were lost to follow-up. A total of 310 patients were analyzed for the study. The mean age was 76.6 years. Of these, 52.6% of patients used low dose apixaban. A total of 309 (99.7%) patients were covered by the National Health Insurance. The rate of concurrent use of antiplatelet therapy was 13.2 percent. Adverse events were reported in 17 (5.5%) patients, and were mostly non-major bleeding events. The appropriate medication adherence rate was 93.2 percent. This study showed that the rates of National Health Insurance coverage and medication adherence were more than 90 percent. In real clinical practice, low doses of apixaban were used more than 50% because of the bleeding risk in older aged patients. Because long-term use of apixaban is prescribed for elderly patients with non-valvular atrial fibrillation, pharmacists must take active roles in counseling and close monitoring of adverse events to improve medication adherence.

목차

등록된 정보가 없습니다.

참고문헌 (28)

참고문헌 신청
Harrington AR / 2013 / Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation / Stroke 44(6):1676~1681 google schola Holbrook AM / 2005 / Systematic overview of warfarin and its drug and food interactions / Arch Intern Med 165(10):1095~1106 google schola Gage BF / 2000 / Management and dosing of warfarin therapy / AmJ Med 109(6):481~488 google schola FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with nonvalvular atrial fibrillation google schola Harder S / 2013 / Novel oral anticoagulants : Clinical pharmacology, indications and practical considerations / Eur J Clin Pharmacol 69(9):1617~1633 google schola

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0